| Product Code: ETC7212483 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, France continues to see a steady import flow of argatroban, with top exporting countries including Ireland, China, USA, Switzerland, and Belgium. The market remains relatively competitive with low concentration levels, indicating a diverse range of sources. Despite a modest Compound Annual Growth Rate (CAGR) of 1.74% from 2020 to 2024, there was a notable decrease in growth rate from 2023 to 2024 at -18.61%. This fluctuation suggests a potential shift in market dynamics or external factors impacting the import landscape for argatroban in France.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Argatroban Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Argatroban Market Revenues & Volume, 2021 & 2031F |
3.3 France Argatroban Market - Industry Life Cycle |
3.4 France Argatroban Market - Porter's Five Forces |
3.5 France Argatroban Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 France Argatroban Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 France Argatroban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in France |
4.2.2 Growing awareness about the benefits of argatroban in treating thrombosis |
4.2.3 Rising geriatric population in France leading to higher demand for anticoagulants |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in France |
4.3.2 Competition from alternative anticoagulant drugs in the market |
5 France Argatroban Market Trends |
6 France Argatroban Market, By Types |
6.1 France Argatroban Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Argatroban Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 France Argatroban Market Revenues & Volume, By Argatroban Powder, 2021- 2031F |
6.1.4 France Argatroban Market Revenues & Volume, By Argatroban Injection, 2021- 2031F |
6.2 France Argatroban Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Argatroban Market Revenues & Volume, By Heparin-induced Thrombocytopenia (HIT), 2021- 2031F |
6.2.3 France Argatroban Market Revenues & Volume, By Percutaneous Coronary Intervention, 2021- 2031F |
6.2.4 France Argatroban Market Revenues & Volume, By Cerebral Arterial Thrombosis, 2021- 2031F |
6.2.5 France Argatroban Market Revenues & Volume, By Others, 2021- 2031F |
7 France Argatroban Market Import-Export Trade Statistics |
7.1 France Argatroban Market Export to Major Countries |
7.2 France Argatroban Market Imports from Major Countries |
8 France Argatroban Market Key Performance Indicators |
8.1 Number of clinical trials conducted on argatroban in France |
8.2 Adoption rate of argatroban by healthcare providers in France |
8.3 Patient satisfaction levels with argatroban treatment in France |
9 France Argatroban Market - Opportunity Assessment |
9.1 France Argatroban Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Argatroban Market Opportunity Assessment, By Application, 2021 & 2031F |
10 France Argatroban Market - Competitive Landscape |
10.1 France Argatroban Market Revenue Share, By Companies, 2024 |
10.2 France Argatroban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |